# FreightCar America, Inc.: financial statements, quarterly

RAIL · Nasdaq · CIK 1320854 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rail.md) · [Financials](/companies/rail/financials.md) · [Filings](/companies/rail/filings.md) · [Insiders](/companies/rail/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rail/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [61.7](/filings/0000950170-24-124596.md) | [126 d](/filings/0000950170-25-037977.md) | [161](/filings/0000950170-25-063571.md) | [146](/filings/0000950170-25-102028.md) | [113](/filings/0001193125-25-273281.md) | [138 d](/filings/0001193125-26-098668.md) | [96.2](/filings/0000950170-25-063571.md) | [119](/filings/0000950170-25-102028.md) | [160](/filings/0001193125-25-273281.md) | [125 d](/filings/0001193125-26-098668.md) | [64.3](/filings/0001320854-26-000010.md) | [113](/filings/0001193125-26-330623.md) |
| Cost of revenue | $m | [52.7](/filings/0000950170-24-124596.md) | [115 d](/filings/0000950170-25-037977.md) | [150](/filings/0000950170-25-063571.md) | [129](/filings/0000950170-25-102028.md) | [97.1](/filings/0001193125-25-273281.md) | [117 d](/filings/0001193125-26-098668.md) | [81.9](/filings/0001320854-26-000010.md) | [101](/filings/0001193125-26-330623.md) | [136](/filings/0001193125-25-273281.md) | [109 d](/filings/0001193125-26-098668.md) | [53.5](/filings/0001320854-26-000010.md) | [107](/filings/0001193125-26-330623.md) |
| Gross profit | $m | [9.2](/filings/0000950170-24-124596.md) | [12.1 d](/filings/0000950170-25-037977.md) | [11.4](/filings/0000950170-25-063571.md) | [18.4](/filings/0000950170-25-102028.md) | [16.2](/filings/0001193125-25-273281.md) | [21.0 d](/filings/0001193125-26-098668.md) | [14.4](/filings/0001320854-26-000010.md) | [17.8](/filings/0001193125-26-330623.md) | [24.2](/filings/0001193125-25-273281.md) | [16.8 d](/filings/0001193125-26-098668.md) | [10.8](/filings/0001320854-26-000010.md) | [6.2](/filings/0001193125-26-330623.md) |
| Selling, general and administrative | $m | [7.5](/filings/0000950170-24-124596.md) | [7.7 d](/filings/0000950170-25-037977.md) | [7.5](/filings/0000950170-25-063571.md) | [8.5](/filings/0000950170-25-102028.md) | [7.5](/filings/0001193125-25-273281.md) | [9.4 d](/filings/0001193125-26-098668.md) | [10.5](/filings/0001320854-26-000010.md) | [10.1](/filings/0001193125-26-330623.md) | [9.6](/filings/0001193125-25-273281.md) | [9.0 d](/filings/0001193125-26-098668.md) | [11.4](/filings/0001320854-26-000010.md) | [10.5](/filings/0001193125-26-330623.md) |
| Operating income | $m | [1.4](/filings/0000950170-24-124596.md) | [0.3 d](/filings/0000950170-25-037977.md) | [3.9](/filings/0000950170-25-063571.md) | [13.1](/filings/0000950170-25-102028.md) | [8.7](/filings/0001193125-25-273281.md) | [11.6 d](/filings/0001193125-26-098668.md) | [3.9](/filings/0001320854-26-000010.md) | [7.7](/filings/0001193125-26-330623.md) | [14.6](/filings/0001193125-25-273281.md) | [7.8 d](/filings/0001193125-26-098668.md) | [(0.6)](/filings/0001320854-26-000010.md) | [(4.3)](/filings/0001193125-26-330623.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.2](/filings/0000950170-24-124596.md) | [0.6 d](/filings/0000950170-25-037977.md) | [(2.6)](/filings/0000950170-25-063571.md) | [2.5](/filings/0000950170-25-102028.md) | [3.4](/filings/0001193125-25-273281.md) | [2.5 d](/filings/0001193125-26-098668.md) | [1.8](/filings/0001320854-26-000010.md) | [(52.7)](/filings/0001193125-26-330623.md) | [(0.1)](/filings/0001193125-25-273281.md) | [2.0 d](/filings/0001193125-26-098668.md) | [3.7](/filings/0001320854-26-000010.md) | [(2.3)](/filings/0001193125-26-330623.md) |
| Net income | $m | [3.2](/filings/0000950170-24-124596.md) | [(2.9) d](/filings/0000950170-25-037977.md) | [(11.6)](/filings/0000950170-25-063571.md) | [8.2](/filings/0000950170-25-102028.md) | [(107)](/filings/0001193125-25-273281.md) | [34.6 d](/filings/0001193125-26-098668.md) | [50.4](/filings/0001320854-26-000010.md) | [11.7](/filings/0001193125-26-330623.md) | [(7.4)](/filings/0001193125-25-273281.md) | [(16.6) d](/filings/0001193125-26-098668.md) | [41.6](/filings/0001320854-26-000010.md) | [(30.1)](/filings/0001193125-26-330623.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0000950170-24-124596.md) | not reported | [(0.54)](/filings/0000950170-25-063571.md) | [0.11](/filings/0000950170-25-102028.md) | [(3.57)](/filings/0001193125-25-273281.md) | not reported | [1.52](/filings/0001320854-26-000010.md) | [0.34](/filings/0001193125-26-330623.md) | [(0.23)](/filings/0001193125-25-273281.md) | not reported | [1.15](/filings/0001320854-26-000010.md) | [(0.94)](/filings/0001193125-26-330623.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0000950170-24-124596.md) | not reported | [(0.54)](/filings/0000950170-25-063571.md) | [0.12](/filings/0000950170-25-102028.md) | [(3.57)](/filings/0001193125-25-273281.md) | not reported | [1.54](/filings/0001320854-26-000010.md) | [0.36](/filings/0001193125-26-330623.md) | [(0.23)](/filings/0001193125-25-273281.md) | not reported | [1.27](/filings/0001320854-26-000010.md) | [(0.94)](/filings/0001193125-26-330623.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [158](/filings/0000950170-23-059464.md) | [180](/filings/0000950170-25-037977.md) | [171](/filings/0000950170-24-055793.md) | [127](/filings/0000950170-24-095480.md) | [168](/filings/0000950170-24-124596.md) | [145](/filings/0001193125-26-098668.md) | [173](/filings/0000950170-25-063571.md) | [204](/filings/0000950170-25-102028.md) | [221](/filings/0001193125-25-273281.md) | [160](/filings/0001193125-26-330623.md) | [163](/filings/0001320854-26-000010.md) | [151](/filings/0001193125-26-330623.md) |
| Total assets | $m | [229](/filings/0000950170-23-059464.md) | [259](/filings/0000950170-25-037977.md) | [249](/filings/0000950170-24-055793.md) | [207](/filings/0000950170-24-095480.md) | [246](/filings/0000950170-24-124596.md) | [224](/filings/0001193125-26-098668.md) | [250](/filings/0000950170-25-063571.md) | [328](/filings/0000950170-25-102028.md) | [341](/filings/0001193125-25-273281.md) | [290](/filings/0001193125-26-330623.md) | [288](/filings/0001320854-26-000010.md) | [276](/filings/0001193125-26-330623.md) |
| Current liabilities | $m | [85.5](/filings/0000950170-23-059464.md) | [137](/filings/0000950170-25-037977.md) | [122](/filings/0000950170-24-055793.md) | [68.1](/filings/0000950170-24-095480.md) | [105](/filings/0000950170-24-124596.md) | [80.8](/filings/0001193125-26-098668.md) | [108](/filings/0000950170-25-063571.md) | [130](/filings/0000950170-25-102028.md) | [133](/filings/0001193125-25-273281.md) | [85.6](/filings/0001193125-26-330623.md) | [90.3](/filings/0001320854-26-000010.md) | [83.3](/filings/0001193125-26-330623.md) |
| Total liabilities | $m | [190](/filings/0000950170-23-059464.md) | [222](/filings/0000950170-25-037977.md) | [222](/filings/0000950170-24-055793.md) | [172](/filings/0000950170-24-095480.md) | [318](/filings/0000950170-24-124596.md) | [374](/filings/0001193125-26-098668.md) | [348](/filings/0000950170-25-063571.md) | [412](/filings/0000950170-25-102028.md) | [432](/filings/0001193125-25-273281.md) | [397](/filings/0001193125-26-330623.md) | [353](/filings/0001320854-26-000010.md) | [240](/filings/0001193125-26-330623.md) |
| Long-term debt | $m | [31.1](/filings/0000950170-23-059464.md) | [0.0](/filings/0000950170-25-037977.md) | not reported | not reported | not reported | [106](/filings/0001193125-26-098668.md) | [105](/filings/0000950170-25-063571.md) | [105](/filings/0000950170-25-102028.md) | [105](/filings/0001193125-25-273281.md) | [97.5](/filings/0001193125-26-330623.md) | [98.2](/filings/0001320854-26-000010.md) | [97.9](/filings/0001193125-26-330623.md) |
| Current portion of debt | $m | [0.0](/filings/0000950170-23-059464.md) | [29.4](/filings/0000950170-25-037977.md) | [30.0](/filings/0000950170-24-055793.md) | [0.0](/filings/0000950170-24-095480.md) | [0.0](/filings/0000950170-24-124596.md) | [2.9](/filings/0001193125-26-098668.md) | [2.9](/filings/0000950170-25-063571.md) | [2.9](/filings/0000950170-25-102028.md) | [2.9](/filings/0001193125-25-273281.md) | [9.7](/filings/0001193125-26-330623.md) | [2.9](/filings/0001320854-26-000010.md) | [2.9](/filings/0001193125-26-330623.md) |
| Shareholders' equity | $m | [(44.3)](/filings/0000950170-23-059464.md) | [(46.2)](/filings/0001193125-26-098668.md) | [(57.0)](/filings/0000950170-25-102028.md) | [(48.8)](/filings/0001193125-25-273281.md) | [(156)](/filings/0001193125-25-273281.md) | [(150)](/filings/0001193125-26-330623.md) | [(97.4)](/filings/0001193125-26-330623.md) | [(83.5)](/filings/0001193125-26-330623.md) | [(90.9)](/filings/0001193125-25-273281.md) | [(107)](/filings/0001193125-26-330623.md) | [(65.3)](/filings/0001193125-26-330623.md) | [36.2](/filings/0001193125-26-330623.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.8) d](/filings/0000950170-24-124596.md) | [31.2 d](/filings/0000950170-25-037977.md) | [(25.3)](/filings/0000950170-25-063571.md) | [57.2 d](/filings/0000950170-25-102028.md) | [7.2 d](/filings/0001193125-25-273281.md) | [5.9 d](/filings/0001193125-26-098668.md) | [12.8](/filings/0001320854-26-000010.md) | [8.5 d](/filings/0001193125-26-330623.md) | [3.4 d](/filings/0001193125-25-273281.md) | [10.0 d](/filings/0001193125-26-098668.md) | [(4.3)](/filings/0001320854-26-000010.md) | [12.1 d](/filings/0001193125-26-330623.md) |
| Capital expenditure | $m | [4.0 d](/filings/0000950170-24-124596.md) | [3.8 d](/filings/0000950170-25-037977.md) | [1.0](/filings/0000950170-25-063571.md) | [1.3 d](/filings/0000950170-25-102028.md) | [1.5 d](/filings/0001193125-25-273281.md) | [1.3 d](/filings/0001193125-26-098668.md) | [0.3](/filings/0001320854-26-000010.md) | [0.6 d](/filings/0001193125-26-330623.md) | [1.2 d](/filings/0001193125-25-273281.md) | [1.3 d](/filings/0001193125-26-098668.md) | [0.1](/filings/0001320854-26-000010.md) | [0.7 d](/filings/0001193125-26-330623.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.7](/filings/0000950170-23-059464.md) | [26.5](/filings/0000950170-24-055793.md) | [28.1](/filings/0000950170-24-095480.md) | [29.5](/filings/0000950170-24-124596.md) | [29.6](/filings/0000950170-25-063571.md) | [32.3](/filings/0000950170-25-102028.md) | [31.4](/filings/0001193125-25-273281.md) | [33.3](/filings/0001320854-26-000010.md) | [33.4](/filings/0001193125-26-330623.md) | [31.9](/filings/0001193125-25-273281.md) | [35.5](/filings/0001320854-26-000010.md) | [31.9](/filings/0001193125-26-330623.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 32,791,280 at 2026-07-31, from the cover of the [10-Q filed 2026-08-03](/filings/0001193125-26-330623.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.